Skip to content
Trial Eligibility
Menu

Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees

NCT06590402

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are: To measure postoperative functional outcomes in patients who received AFCNB vs. ACB. To calculate postoperative opioid requirements in pediatric knee surgeries that received AFCNB vs. ACB. To calculate pain intensity levels at rest and with ambulation in patients who received AFCNB vs. ACB.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Anterior Cruciate Ligament Reconstruction
  • Medial Patellofemoral Ligament Reconstruction

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
8 to 18 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Hospital for Special Surgery, New York
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Hospital for Special Surgery · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.